Skip to main content

Table 4 Subgroup analysis of characteristics of non-frail and frail patients with diabetes

From: Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes

Variable

Non-frail (n = 340)

Frail (n = 82)

Non-metformin (n = 127)

Metformin (n = 213)

P value

Non-metformin (n = 50)

Metformin (n = 32)

P value

Age (years)

71.2 ± 10.39

65.84 ± 8.51

 < 0.001

83.95 ± 6.22

75.78 ± 9.62

 < 0.001

Female (n, %)

44 (34.6)

80 (37.6)

0.589

18 (36.0)

10 (31.3)

0.658

WHR

0.95 ± 0.07

0.95 ± 0.10

0.220

1.14 ± 1.28

0.97 ± 0.06

0.211

BMI (kg/m2)

25.07 ± 3.44

26.32 ± 2.94

0.001

25.05 ± 4.17

25.55 ± 4.03

0.582

Smoking (n, %)

55 (43.3)

103 (48.4)

0.366

21 (42.0)

15 (46.9)

0.664

Drinking (n, %)

45 (35.4)

85 (40.1)

0.393

8 (16.0)

15 (48.4)

0.002

Duration (years)

10.44 ± 9.34

11.63 ± 8.12

0.048

12.85 ± 8.60

11.78 ± 8.87

0.415

Comorbidity

Hypertension (n, %)

100 (78.7)

156 (73.2)

0.255

45 (90.0)

29 (90.6)

0.926

CAD (n, %)

53 (41.7)

58 (27.2)

0.006

35 (70.0)

15 (46.9)

0.036

COPD (n, %)

6 (4.7)

7 (3.3)

0.706

5 (100.0)

0 (0.0)

0.078

CKD (n, %)

20 (15.7)

14 (6.6)

0.006

20 (40.0)

2 (6.3)

0.001

Stoke (n, %)

24 (18.9)

34 (16.0)

0.486

15 (30.0)

15 (46.9)

0.122

Osteoarthritis (n, %)

26 (20.5)

26 (12.2)

0.041

19 (38.0)

10 (31.3)

0.533

Cancer (n, %)

10 (7.9)

22 (10.3)

0.453

17 (34.0)

6 (18.8)

0.134

Target organ damage

PVD (n, %)

22 (17.3)

21 (9.9)

0.045

16 (32.0)

7 (21.9)

0.319

DR (n, %)

13 (10.2)

32 (15.0)

0.208

4 (8.0)

3 (9.4)

0.564

DPN (n, %)

13 (10.2)

31 (14.6)

0.251

9 (18.0)

10 (31.3)

0.165

Polypharmacy (n, %)

77 (60.6)

126 (59.2)

0.789

41 (82.0)

27 (84.4)

0.780

Grip strength (kg)

29.86 ± 9.53

30.78 ± 9.52

0.383

17.62 ± 7.08

19.09 ± 7.10

0.304

Walking speed (m/s)

0.99 ± 0.26

1.02 ± 0.27

0.361

0.55 ± 0.19

0.64 ± 0.24

0.109

SF-36 score

113.32 ± 10.14

116.76 ± 7.16

0.008

98.10 ± 9.46

104.34 ± 12.94

0.026

  1. Data for continuous variables are presented as mean ± (standard deviation) or median (interquartile range). Data for categorical variables are presented as n (percentage)
  2. WHR, waist-to-hip ratio; BMI, body mass index; CAD, coronary atherosclerotic heart disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; PVD, peripheral vascular disease; DR, diabetic retinopathy; DPN, diabetic peripheral neuropathy